I. Amanam

发表

Novel Therapies for Small Cell Lung Cancer

M. Koczywas, I. Amanam, Idoroenyi Amanam, 2019, Targeted Therapies for Lung Cancer.

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.

J. Ross, E. Sokol, V. Miller, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Multiple Myeloma

A. Krishnan, I. Amanam, N. Nathwani, 2019, Oncology in the Precision Medicine Era.

Chronic Myelomonocytic Leukemia (CMML): A systematic Review of Literature and Update

H. Ali, S. Otoukesh, I. Amanam, 2022, Journal of Cancer Science and Clinical Therapeutics.

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.

E. Sokol, V. Miller, M. Fakih, 2019 .

Progress and Trends for Cancer Drug Approval – an Analysis of FDA Advisory Committee

B. Monk, J. Chan, D. Kapp, 2012 .

Characteristics and Trends of Adult Acute Lymphoblastic Leukemia in a Large, Public Safety-Net Hospital.

I. Aldoss, V. Pullarkat, Tamer Othman, 2020, Clinical lymphoma, myeloma & leukemia.

Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML).

G. Marcucci, I. Aldoss, P. Curtin, 2022, Leukemia & lymphoma.

Current and future therapies for advanced pancreatic cancer

V. Chung, I. Amanam, Rohan Gupta, 2017, Journal of surgical oncology.

Targeted Therapies in Non-small-Cell Lung Cancer.

R. Salgia, Dan Zhao, Addie Hill, 2019, Cancer treatment and research.

Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival

R. Salgia, Isa Mambetsariev, K. Reckamp, 2020, Journal of thoracic disease.

The brigatinib experience: a new generation of therapy for ALK-positive non-small-cell lung cancer.

R. Salgia, Isa Mambetsariev, I. Amanam, 2018, Future oncology.

Precision medicine and actionable alterations in lung cancer: A single institution experience

Lynette M. Smith, A. Bild, S. Batra, 2020, PloS one.

Perspectives in Head and Neck Medical Oncology.

A. Mita, E. Massarelli, K. Scher, 2018, Cancer treatment and research.

Mutation and immune profiling of metaplastic breast cancer: Correlation with survival

P. Frankel, J. Mortimer, P. Aoun, 2019, PloS one.

Targeted Therapies for Pancreatic Cancer

V. Chung, I. Amanam, Idoroenyi Amanam, 2018, Cancers.

Therapeutic antibodies: A new era in the treatment of respiratory diseases?

L. Plantier, T. Sécher, N. Heuzé-Vourc’h, 2018, Pharmacology & therapeutics.

Post-transplant sinusoidal obstruction syndrome in adult patients with B-cell Acute Lymphoblastic Leukemia treated with pre-transplant Inotuzumab.

G. Marcucci, I. Aldoss, P. Curtin, 2023, Transplantation and cellular therapy.

Tacrolimus initial steady state level in post-transplant cyclophosphamide based GvHD prophylaxis regimens

G. Marcucci, I. Aldoss, S. Forman, 2021, Bone Marrow Transplantation.

Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study

G. Marcucci, I. Aldoss, S. Forman, 2023, Frontiers in Immunology.

Inotuzumab ozogamicin is deliverable in relapsed ALL patients with end-stage renal disease on hemodialysis

I. Aldoss, V. Pullarkat, I. Amanam, 2022, Leukemia & lymphoma.

Lower tumor mutational burden (TMB) and hepatic metastases may predict for lack of response to PD-1 blockade in MSI-H metastatic colorectal cancer (MCRC).

M. Fakih, S. Rahmanuddin, A. Schrock, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Anaplastic Lymphoma Kinase (ALK)-positive Tumors

R. Salgia, Isa Mambetsariev, S. Rahmanuddin, 2019, American journal of clinical oncology.

High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia‐like fusions

G. Marcucci, I. Aldoss, P. Curtin, 2023, American journal of hematology.

The Characteristics and Prognosis of Patients with Clonal Cytopenias of Undetermined Significance, Including Cancer and Therapy-Related Clonal Cytopenias

Ashutosh Kumar Singh, L. Adès, H. Carraway, 2022, Blood.

Immune thrombocytopenia after immune checkpoint inhibitor therapy

V. Pullarkat, I. Amanam, M. Mei, 2021, British journal of haematology.

Applications for oncologic drugs: a descriptive analysis of the oncologic drugs advisory committee reviews.

B. Monk, J. Chan, D. Kapp, 2014, The oncologist.

Tocilizumab for Cytokine Release Syndrome Management after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.

G. Marcucci, I. Aldoss, P. Curtin, 2023, Transplantation and cellular therapy.

Outcomes of Venetoclax and Hypomethylating Agents (HMA) in Adult Patients with KMT2A-Rearranged Leukemias

G. Marcucci, I. Aldoss, A. Salhotra, 2021, Blood.

Chronic GVHD: review advances in prevention, novel endpoints, and targeted strategies.

A. Salhotra, M. A. Al Malki, S. Otoukesh, 2023, Hematology. American Society of Hematology. Education Program.